RECURSION PHARMACEUTICALS, INC. - RXRX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 08, 2026 | — | C | D | 40,000.0 | 0.0 | 0.0 | 4,443,334.0 | View | |
| Apr 08, 2026 | — | S | D | 40,000.0 | 3.1 | 124,000.0 | 906,556.0 | View | |
| Apr 08, 2026 | — | C | A | 40,000.0 | 0.0 | 0.0 | 946,556.0 | View | |
| Apr 08, 2026 | — | S | D | 30,000.0 | 3.1 | 93,000.0 | 6,229,863.0 | View | |
| Apr 08, 2026 | Chief Financial Officer | F | D | 48,028.0 | 3.11 | 149,367.08 | 1,132,290.0 | View | |
| Apr 02, 2026 | — | A | A | 4,902.0 | 0.0 | 0.0 | 147,231.0 | View | |
| Apr 02, 2026 | — | A | A | 3,268.0 | 0.0 | 0.0 | 1,244,177.0 | View | |
| Mar 25, 2026 | — | C | D | 40,000.0 | 0.0 | 0.0 | 4,483,334.0 | View | |
| Mar 25, 2026 | — | S | D | 40,000.0 | 3.25 | 130,000.0 | 906,556.0 | View | |
| Mar 25, 2026 | — | C | A | 40,000.0 | 0.0 | 0.0 | 946,556.0 | View | |
| Mar 18, 2026 | Chief Financial Officer | S | D | 7,956.0 | 3.39 | 26,970.84 | 1,180,318.0 | View | |
| Mar 18, 2026 | Chief Financial Officer | F | D | 7,075.0 | 3.42 | 24,196.5 | 1,188,274.0 | View | |
| Mar 11, 2026 | — | C | D | 20,000.0 | 0.0 | 0.0 | 4,523,334.0 | View | |
| Mar 11, 2026 | — | G | D | 20,000.0 | 0.0 | 0.0 | 906,556.0 | View | |
| Mar 11, 2026 | — | C | A | 20,000.0 | 0.0 | 0.0 | 926,556.0 | View | |
| Mar 11, 2026 | CEO and President | S | D | 28,298.0 | 3.3451 | 94,659.64 | 2,262,085.0 | View | |
| Mar 04, 2026 | — | S | D | 170,000.0 | 3.46 | 588,200.0 | 6,259,863.0 | View | |
| Feb 19, 2026 | Chief Financial Officer | S | D | 13,426.0 | 3.08 | 41,352.08 | 1,195,349.0 | View | |
| Feb 19, 2026 | Chief Financial Officer | F | D | 11,908.0 | 3.49 | 41,558.92 | 1,208,775.0 | View | |
| Feb 19, 2026 | — | C | D | 40,000.0 | 0.0 | 0.0 | 4,543,334.0 | View | |
| Feb 19, 2026 | — | S | D | 40,000.0 | 3.46 | 138,400.0 | 906,556.0 | View | |
| Feb 19, 2026 | — | C | A | 40,000.0 | 0.0 | 0.0 | 946,556.0 | View | |
| Feb 19, 2026 | — | F | D | 27,265.0 | 3.49 | 95,154.85 | 906,556.0 | View | |
| Feb 19, 2026 | Chief Scientific Officer | F | D | 11,908.0 | 3.49 | 41,558.92 | 1,097,151.0 | View | |
| Feb 19, 2026 | CEO and President | F | D | 14,280.0 | 3.49 | 49,837.2 | 2,290,383.0 | View | |
| Feb 10, 2026 | Chief Financial Officer | F | D | 11,400.0 | 3.98 | 45,372.0 | 1,220,683.0 | View | |
| Feb 10, 2026 | Chief Financial Officer | A | A | 24,254.0 | 0.0 | 0.0 | 1,232,083.0 | View | |
| Feb 10, 2026 | Chief Financial Officer | A | A | 446,279.0 | 0.0 | 0.0 | 1,207,829.0 | View | |
| Feb 10, 2026 | CEO and President | F | D | 10,364.0 | 3.98 | 41,248.72 | 2,304,663.0 | View | |
| Feb 10, 2026 | CEO and President | A | A | 30,346.0 | 0.0 | 0.0 | 2,315,027.0 | View | |
| Feb 10, 2026 | CEO and President | A | A | 1,673,546.0 | 0.0 | 0.0 | 2,284,681.0 | View | |
| Feb 10, 2026 | Chief Scientific Officer | F | D | 11,400.0 | 3.98 | 45,372.0 | 1,109,059.0 | View | |
| Feb 10, 2026 | Chief Scientific Officer | A | A | 24,254.0 | 0.0 | 0.0 | 1,120,459.0 | View | |
| Feb 10, 2026 | Chief Scientific Officer | A | A | 502,064.0 | 0.0 | 0.0 | 1,096,205.0 | View | |
| Feb 06, 2026 | — | S | D | 220,000.0 | 4.2 | 924,000.0 | 6,429,863.0 | View | |
| Feb 06, 2026 | — | C | D | 40,000.0 | 0.0 | 0.0 | 4,583,334.0 | View | |
| Feb 06, 2026 | — | F | D | 10,364.0 | 3.56 | 36,895.84 | 933,821.0 | View | |
| Feb 06, 2026 | — | A | A | 30,346.0 | 0.0 | 0.0 | 944,185.0 | View | |
| Feb 06, 2026 | — | S | D | 40,000.0 | 4.12 | 164,800.0 | 913,839.0 | View | |
| Feb 06, 2026 | — | C | A | 40,000.0 | 0.0 | 0.0 | 953,839.0 | View | |
| Jan 22, 2026 | — | C | D | 40,000.0 | 0.0 | 0.0 | 4,623,334.0 | View | |
| Jan 22, 2026 | — | S | D | 40,000.0 | 4.47 | 178,800.0 | 913,839.0 | View | |
| Jan 22, 2026 | — | C | A | 40,000.0 | 0.0 | 0.0 | 953,839.0 | View | |
| Jan 08, 2026 | — | S | D | 220,000.0 | 4.36 | 959,200.0 | 6,649,863.0 | View | |
| Jan 07, 2026 | — | C | D | 60,000.0 | 0.0 | 0.0 | 4,663,334.0 | View | |
| Jan 07, 2026 | — | G | D | 20,000.0 | 0.0 | 0.0 | 913,839.0 | View | |
| Jan 07, 2026 | — | S | D | 40,000.0 | 4.25 | 170,000.0 | 933,839.0 | View | |
| Jan 07, 2026 | — | C | A | 60,000.0 | 0.0 | 0.0 | 973,839.0 | View | |
| Jan 06, 2026 | — | A | A | 3,571.0 | 0.0 | 0.0 | 142,329.0 | View | |
| Jan 06, 2026 | — | A | A | 2,381.0 | 0.0 | 0.0 | 1,240,909.0 | View | |
| Dec 30, 2025 | Chief Financial Officer | S | D | 21,383.0 | 4.18 | 89,380.94 | 761,550.0 | View | |
| Dec 29, 2025 | Chief R&D Commercial Officer | S | D | 124,403.0 | 4.4098 | 548,592.35 | 611,135.0 | View | |
| Dec 19, 2025 | Chief Executive Officer | C | D | 40,000.0 | 0.0 | 0.0 | 4,723,334.0 | View | |
| Dec 19, 2025 | Chief Executive Officer | S | D | 40,000.0 | 4.5 | 180,000.0 | 913,839.0 | View | |
| Dec 19, 2025 | Chief Executive Officer | C | A | 40,000.0 | 0.0 | 0.0 | 953,839.0 | View | |
| Dec 17, 2025 | Chief Financial Officer | F | D | 7,057.0 | 4.33 | 30,556.81 | 782,933.0 | View | |
| Dec 05, 2025 | Chief Executive Officer | C | D | 60,000.0 | 0.0 | 0.0 | 4,763,334.0 | View | |
| Dec 05, 2025 | Chief Executive Officer | G | D | 20,000.0 | 0.0 | 0.0 | 913,839.0 | View | |
| Dec 05, 2025 | Chief Executive Officer | S | D | 40,000.0 | 4.63 | 185,200.0 | 933,839.0 | View | |
| Dec 05, 2025 | Chief Executive Officer | C | A | 60,000.0 | 0.0 | 0.0 | 973,839.0 | View | |
| Dec 04, 2025 | — | S | D | 220,000.0 | 4.37 | 961,400.0 | 6,869,863.0 | View | |
| Nov 26, 2025 | Chief Financial Officer | F | D | 2,271.0 | 4.03 | 9,152.13 | 789,990.0 | View | |
| Nov 19, 2025 | Chief R&D Commercial Officer | F | D | 17,584.0 | 4.14 | 72,797.76 | 735,538.0 | View | |
| Nov 19, 2025 | Chief Financial Officer | F | D | 11,908.0 | 4.14 | 49,299.12 | 792,261.0 | View | |
| Nov 19, 2025 | Chief Executive Officer | C | D | 40,000.0 | 0.0 | 0.0 | 4,823,334.0 | View | |
| Nov 19, 2025 | Chief Executive Officer | S | D | 40,000.0 | 4.16 | 166,400.0 | 913,839.0 | View | |
| Nov 19, 2025 | Chief Executive Officer | C | A | 40,000.0 | 0.0 | 0.0 | 953,839.0 | View | |
| Nov 19, 2025 | Chief Executive Officer | F | D | 40,390.0 | 4.14 | 167,214.6 | 913,839.0 | View | |
| Nov 06, 2025 | Chief Executive Officer | C | D | 60,000.0 | 0.0 | 0.0 | 4,863,334.0 | View | |
| Nov 06, 2025 | Chief Executive Officer | G | D | 20,000.0 | 0.0 | 0.0 | 954,229.0 | View | |
| Nov 06, 2025 | Chief Executive Officer | S | D | 40,000.0 | 5.21 | 208,400.0 | 974,229.0 | View | |
| Nov 06, 2025 | Chief Executive Officer | C | A | 60,000.0 | 0.0 | 0.0 | 1,014,229.0 | View | |
| Nov 06, 2025 | Chief R&D Commercial Officer | A | A | 169,851.0 | 0.0 | 0.0 | 169,851.0 | View | |
| Nov 06, 2025 | Chief R&D Commercial Officer | A | A | 84,925.0 | 0.0 | 0.0 | 753,122.0 | View | |
| Oct 24, 2025 | Chief Executive Officer | C | D | 100,000.0 | 0.0 | 0.0 | 4,923,334.0 | View | |
| Oct 24, 2025 | Chief Executive Officer | S | D | 100,000.0 | 5.7 | 570,000.0 | 954,229.0 | View | |
| Oct 24, 2025 | Chief Executive Officer | C | A | 100,000.0 | 0.0 | 0.0 | 1,054,229.0 | View |